Robin A. Fairhurst

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Novartis (Switzerland)18.4%
• Novartis Institutes for BioMedical Research12.2%
• Inserm8.2%
• Jinan University6.4%
• Xenon Pharmaceuticals (Canada)6.4%
• Harvard University6.3%
• Other42%

Fields

• Biochemistry, Genetics and Molecular Biology56.7%
• Medicine22.6%
• Chemistry7.4%
• Pharmacology, Toxicology and Pharmaceutics4.9%
• Computer Science3.3%
• Neuroscience1.9%
• Other3.3%

Topics

• PI3K/AKT/mTOR signaling in cancer18.6%
• Fibroblast Growth Factor Research10.6%
• Receptor Mechanisms and Signaling7.8%
• Kruppel-like factors research6.7%
• Chronic Lymphocytic Leukemia Research6.5%
• Click Chemistry and Applications6.3%
• Other43.4%